Related Experiment Videos
Standardization of prothrombin times in newborn infants
M Pinto1, L Mitchell, P McCusker
1Department of Paediatrics, McMaster University Medical Centre, Hamilton, Ontario, Canada.
Insights
Thromboplastin reagents cause variable prothrombin time (PT) results in neonatal plasma. Using the international normalized ratio (INR) standardizes these PT values, reducing variability for better clinical interpretation.
Area of Science:
- Clinical Chemistry
- Hematology
- Pediatric Medicine
Background:
- Prothrombin time (PT) testing is crucial for monitoring warfarin therapy.
- Significant variability exists in PT results due to thromboplastin reagent differences.
- The International Normalized Ratio (INR) is recommended to standardize PT values.
Purpose of the Study:
- To investigate the impact of thromboplastin reagent variability on PT measurements in neonatal plasma.
- To evaluate the effectiveness of the INR in reducing PT variability in neonates.
Main Methods:
- Comparison of PT values across different thromboplastin reagents using neonatal plasma samples.
- Calculation and analysis of INR values derived from PT measurements.
- Statistical analysis to assess the degree of variability reduction.
Main Results:
- Thromboplastin reagents significantly influenced PT values in neonatal plasma.
- Expressing PT values as INR decreased the observed variability in neonatal samples.
- INR standardization proved effective in mitigating reagent-induced PT variations.
Conclusions:
- Reagent-dependent variability is a significant factor in neonatal PT testing.
- The international normalized ratio (INR) is a valuable tool for standardizing PT results in neonates.
- Standardized PT measurements are essential for accurate clinical assessment in pediatric patients.
Abstract:
The prothrombin time (PT) for patients receiving warfarin varies widely, reflecting the heterogeneity of thromboplastin reagents. The International Committee on Thrombosis and Haemostasis recommends that PT values for these patients be expressed as international normalized ratios. This study showed that thromboplastin reagents also significantly influence PT values in neonatal plasma and that expressing PT values as international normalized ratios decreases this variability.